Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
634 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00276055 | Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma | completed | Phase 1 | 38 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01174537 | New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma | withdrawn | Phase 1 / Phase 2 | 0 | Hadassah Medical OrganizationOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT00626704 | Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 134 | AmgenINDUSTRY | 0 | May 25, 2015 | clinicaltrials |
| NCT01010958 | Adjuvant Valproate for High Grade Sarcomas | terminated | Phase 1 | 7 | Columbia UniversityOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT00020150 | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00427414 | Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma | terminated | Phase 1 | 14 | AIDS Malignancy ConsortiumNETWORK | 2 | Apr 29, 2015 | clinicaltrials |
| NCT00233948 | Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma | terminated | Phase 1 / Phase 2 | 29 | City of Hope Medical CenterOTHER | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00187174 | Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors | completed | Phase 1 | 41 | St. Jude Children's Research HospitalOTHER | 1 | Mar 4, 2015 | clinicaltrials |
| NCT01518413 | Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors | completed | Phase 1 | 17 | HMeanyOTHER | 1 | Feb 27, 2015 | clinicaltrials |
| NCT01426633 | Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas | completed | Phase 1 | 5 | Heidelberg UniversityOTHER | 1 | Dec 16, 2014 | clinicaltrials |
| NCT01477021 | Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 6 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 11, 2014 | clinicaltrials |
| NCT02283502 | Clinical Test of the MRgHIFU System on Uterine Fibroids(MRgHIFU) | unknown | Phase 1 | 20 | Chin-Jung WangOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT01281865 | Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00515931 | Radiation Therapy as Palliative Treatment of GIST(GIST-RT) | completed | Phase 1 / Phase 2 | 25 | Heikki JoensuuOTHER | 1 | Oct 7, 2014 | clinicaltrials |
| NCT00093509 | MRI Sarcoma Non Invasive Thermometry | completed | Phase 1 / Phase 2 | 15 | Mark DewhirstOTHER | 1 | Sep 1, 2014 | clinicaltrials |
| NCT00450320 | Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 1 | 7 | AIDS Malignancy ConsortiumNETWORK | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00742924 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | completed | Phase 1 | 24 | Children's Oncology GroupNETWORK | 4 | Jul 4, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00002863 | Cryosurgery in Treating Patients With Soft Tissue Sarcoma | terminated | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01491594 | Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 1 | Duke UniversityOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00003141 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | completed | Phase 1 | 94 | Children's Oncology GroupNETWORK | 3 | Mar 28, 2014 | clinicaltrials |
| NCT00439686 | Study of ZIO-201 in Advanced Sarcoma | completed | Phase 1 / Phase 2 | 53 | Alaunos TherapeuticsINDUSTRY | 1 | Jan 31, 2014 | clinicaltrials |
| NCT01048892 | Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | completed | Phase 1 | 22 | Children's Oncology GroupNETWORK | 1 | Jan 30, 2014 | clinicaltrials |
| NCT01479023 | Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 12 | Washington University School of MedicineOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00101309 | Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma | unknown | Phase 1 | 10 | Milton S. Hershey Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00474760 | Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors | completed | Phase 1 | 65 | PfizerINDUSTRY | 2 | Dec 17, 2013 | clinicaltrials |
| NCT00976508 | Figitumumab Combined With Pegvisomant For Advanced Solid Tumors | terminated | Phase 1 | 24 | PfizerINDUSTRY | 4 | Dec 13, 2013 | clinicaltrials |
| NCT01258634 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | terminated | Phase 1 | 2 | University of ChicagoOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00927966 | RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms | completed | Phase 1 | 21 | Suzanne George, MDOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00929903 | Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT01697514 | A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma | withdrawn | Phase 1 | 0 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
| NCT00002543 | Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | completed | Phase 1 | 3 | Medical College of WisconsinOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00112645 | Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 10 | Milton S. Hershey Medical CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00562380 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | completed | Phase 1 | 64 | AmgenINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00513981 | High-Dose Methotrexate in Treating Young Patients With Solid Tumors | completed | Phase 1 | 36 | Children's Cancer and Leukaemia GroupOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00023725 | Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00023738 | Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00077454 | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 95 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00093821 | Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors | completed | Phase 1 | 70 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00006222 | EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00003207 | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | completed | Phase 1 | 14 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 19, 2015source: clinicaltrials